Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Arch Osteoporos. 2015 Aug 14;10:229. doi: 10.1007/s11657-015-0229-0

Table 2.

New and progressed vertebral fractures in each treatment group during follow up according to level and treatment1

Vertebroplasty group
Fracture type 1 week 1 month 3 months 6 months 1 year (N = 34) 2 years (N = 36) Total
New treated level 12 1
New adjacent level 2 1 3 6
New non-adjacent level 7 1 2 10
Progressed treated level 1 6 5 1 13
Progressed adjacent level 3 0 1 4
Progressed non-adjacent level 3 1 2 6
Total 2 1 20 8 9 40
Placebo group
Fracture type 1 week 1 month 3 months 6 months 1 year (N = 32) 2 years (N = 32) Total
New treated level
New adjacent 1 1 1 3
New non-adjacent 1 3 3 7
Progressed treated level 1 4 3 4 12
Progressed adjacent level 2 2
Progressed non-adjacent level 4 1 4 9
Total 1 1 1 14 4 12 33
1

Radiographs obtained prior to the one year follow up were available only for select participants who presented with new onset pain and radiographs were performed to look for further fractures.

2

This fracture at a treated level was considered to be a new fracture rather than progression of an existing fracture